CIK 0000886744
- Large accelerated filer
GERON CORP
Sign in to watch- Ticker
- GERN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752287752
- Phone
- +1 650-473-7700
- Business address
- 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
- Former names
- GERON CORPORATION
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 35,000 shares at $3.00 ($105,000)
- 4 Open-market sale Director sold 35,000 shares at $2.48 ($86,800)
- 4 Grant or award Director acquired 6,048 shares (grant or award)
- 4 Grant or award Director acquired 3,312 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP, Chief Operating Officer sold 384,719 shares at $3.03 ($1,165,699)
- 4 Open-market sale EVP, Chief Financial Officer sold 400,000 shares at $3.08 ($1,232,000)
- 4 Open-market sale Chairman, President and CEO sold 1,340,000 shares at an average $3.04 ($4,069,133)
- 4 Option exercise Director acquired 35,000 shares (option exercise)
- 4 Grant or award EVP, Corp Strategy & CCO acquired 6,021 shares (grant or award)
- 4 Grant or award Director acquired 2,970 shares (grant or award)
- 4 Grant or award Director acquired 3,071 shares (grant or award)
- 4 Option exercise EVP, Chief Operating Officer acquired 234,719 shares (option exercise)
- 4 Derivatives Options or other derivatives
Page 6 of 35 · 692 filings